UNSPSC 51111621: Acivicin

This classification denotes a glutamine amidotransferase inhibitor with the molecular formula C5H7ClN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O0X60K76I6, chemically known as 5-isoxazoleacetic acid, alpha-amino-3-chloro-4,5-dihydro-, (s-(r*,r*))- but generally known as acivicin, which bears US NIH Compound Identifier 2007. European Medicines Agency schedules Acivicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05241MIG.

UNSPSC 51111621 Acivicin, a Commodity code, addresses pharmaceutical procurement by state and local health agencies seeking direct supplier relationships for prescription medications and related pharmacy benefit services. State and local governments use this code to procure acivicin and related chemotherapy agents, often as part of broader pharmacy benefit management initiatives that bypass traditional pharmacy benefit managers, group purchasing organizations, and wholesalers in favor of direct manufacturer contracts. The issuing bodies under this code include state health departments, state employee health plans, and Medicaid agencies pursuing cost containment and supply-chain efficiency through negotiated net pricing and outcomes-based agreements with manufacturers.

The Texas Health and Human Services Commission issued RFI HHS0017013 (posted April 3, 2026, response due April 3, 2026) seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The RFI solicits information from vendors experienced in direct contracting with self-insured employers and government health plans, flexibility to negotiate without traditional rebate structures, and capability to implement value-based or outcomes-based agreements. This exploratory phase indicates that Texas is gathering market intelligence before issuing a formal RFP with specific financial and temporal parameters. No award value, budget range, or set-aside designations are specified at this stage.